EUVIMEDEUVIMED entdecken
Fallbericht

Validated HPLC‐UV Detection Method for Cefiderocol Quantification in a Critical Patient Receiving Fetcroja and Treated With Extracorporeal Replacement Therapies

Carlos Ezquer-Garin iD, Rafael Ferriols-Lisart iD, Manuel Alós-Almiñana, J A Carbonell, L Hurtado, L García-Vargas, G Aguilar

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70104 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Carlos Ezquer-Garin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Health Research (INCLIVA), University Clinical Hospital of Valencia, Valencia, Spain. Hauptthemen laut MEDLINE: Cephalosporins, Renal Replacement Therapy, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A simple, rapid, and sensitive HPLC‐UV method for cefiderocol quantification in plasma was developed to study the pharmacokinetic profile in a critical patient receiving Fetcroja and treated with a renal replacement therapy. After a quick deproteinization step by an effective precipitation, a chromatographic separation was performed with a C18 column and a mobile phase composed by acetonitrile and phosphate buffer at pH 3.50, delivered by gradient elution at a flow rate of 1.0 mL min −1 . The UV detector was set at 260 nm. Metronidazole was used as an internal standard. A total run time analysis of 15 min was obtained. The method was validated according to the standard guidelines and applied to study the pharmacokinetics of cefiderocol in a critical patient. Total run time analysis obtained was shorter than previously HPLC reported methods, being useful for therapeutic drug monitoring or pharmacokinetic profile research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CephalosporinsRenal Replacement TherapyAnti-Bacterial AgentsChromatography, High Pressure LiquidHumansReproducibility of ResultsSpectrophotometry, UltravioletMaleCritical IllnessLimit of DetectionLinear Models

Stichwörter der Autor:innen

FetcrojaHPLC‐UVcefiderocolcritically ill patientpharmacokinetics

Substanzen

CephalosporinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Institute for Health Research (INCLIVA), University Clinical Hospital of Valencia, Valencia, Spain.
  • Department of Pharmacy, University Clinical Hospital of Valencia, Valencia, Spain.
  • Central Unit for Medical Research of the School of Medicine (UCIM), University of Valencia, Valencia, Spain.
  • Critical Care Unit, Department of Anaesthesiology and Critical Care, University Clinical Hospital of Valencia, Valencia, Spain.
  • School of Medicine, University of Valencia, Valencia, Spain.

ORCID-Profile: Carlos Ezquer-Garin, Rafael Ferriols-Lisart

Zitieren

APA

Ezquer-Garin, C., Ferriols-Lisart, R., Alós-Almiñana, M., Carbonell, J. A., Hurtado, L., García-Vargas, L., & Aguilar, G. (2025). Validated HPLC‐UV Detection Method for Cefiderocol Quantification in a Critical Patient Receiving Fetcroja and Treated With Extracorporeal Replacement Therapies. Biomedical Chromatography. https://doi.org/10.1002/bmc.70104

Vancouver

Ezquer-Garin C, Ferriols-Lisart R, Alós-Almiñana M, Carbonell JA, Hurtado L, García-Vargas L, et al. Validated HPLC‐UV Detection Method for Cefiderocol Quantification in a Critical Patient Receiving Fetcroja and Treated With Extracorporeal Replacement Therapies. Biomedical Chromatography. 2025. doi:10.1002/bmc.70104

BibTeX
@article{EzquerGarin2025,
  author = {Ezquer-Garin, Carlos and Ferriols-Lisart, Rafael and Alós-Almiñana, Manuel and Carbonell, J A and Hurtado, L and García-Vargas, L and Aguilar, G},
  title = {Validated HPLC‐UV Detection Method for Cefiderocol Quantification in a Critical Patient Receiving Fetcroja and Treated With Extracorporeal Replacement Therapies},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70104}
}
Kostenlos starten →